FDA Inspection 1022804 — Stanley Specialty Pharmacy Compounding and Wellness Center
The FDA completed an inspection of Stanley Specialty Pharmacy Compounding and Wellness Center on August 4, 2017 in Charlotte, NC. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 4, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Charlotte, NC (United States)